Fig. 6

Nomogram for the prediction of the survival rate of patients with OS: Nomogram was developed using patient age, sex, metastasis status, and risk score in the TARGET cohort (A); Calibration plots were then used to demonstrate the effectiveness of the nomogram in predicting the 3 and 5-years OS rates of glioma patients in respective cohorts (B-E).